KA Bybee, JH Lee, JH O'Keefe - Current Medical Research and Opinion®, 2008 - informahealthcare.com Kevin a. Bybee, John h. Lee and James h. O'Keefe ... Saint Luke's Mid America
Heart Institute and University of Missouri-Kansas City, Kansas City, MO, USA ... Address for correspondence: James H. O'Keefe, MD, 4330 Wornall Rd, Ste ... Cited by 6 - Related articles - All 5 versions
PS Kruger, NM Freir, B Venkatesh, TA … - Intensive Care Medicine, 2009 - Springer Page 1. Peter S. Kruger Noelle M. Freir Bala Venkatesh Thomas A. Robertson Michael
S. Roberts Mark Jones A preliminary study of atorvastatin plasma ... Cited by 5 - Related articles - All 3 versions
MJ Tikkanen, I Holme, NB Cater, M Szarek, O … - The American journal of cardiology, 2009 - Elsevier The efficacy and safety of atorvastatin (80 mg/day) versus simvastatin (20 to 40
mg/day) in older (age ≥65 years) versus younger (<65 years) patients were
assessed in a prespecified secondary analysis of the 8,888 patients with ... Cited by 4 - Related articles - All 10 versions
AP Nair, B Darrow - Endocrinology and Metabolism Clinics of North …, 2009 - pdf.edocr.com In the United States, the proportion of the population older than 65 years will
increase from 12.4% in 2000 to 19.6% in 2030, and the number of persons older
than 80 years will increase from approximately 9.3 million in 2000 to an ... Cited by 1 - Related articles - View as HTML - All 16 versions
JG Robinson, MH Davidson, A Shah, J Lin, D … - Aging Health, 2007 - Future Medicine Although the greatest burden of cardiovascular disease occurs after age 65
years, limited efficacy and safety data are available for cholesterol-lowering
drugs in elderly patients. We undertook a pooled analysis of individual ... Cited by 1 - Related articles - BL Direct - All 3 versions
C Escobar, R Echarri, V Barrios - Vascular Health and Risk Management, 2008 - pubmedcentral.nih.gov Recent clinical trials recommend achieving a low-density lipoprotein cholesterol
level of <100 mg/dl in high-risk and <70 mg/dl in very high risk patients. To
attain these goals, however, many patients will need statins at high doses. ... Cited by 2 - Related articles - All 7 versions
DD Waters - Progress in Cardiovascular Diseases, 2009 - Elsevier The Treating to New Targets (TNT) trial enrolled 10,001 patients with coronary
disease to treatment with atorvastatin, 80 or 10 mg/d, and observed them for a
median of 4.9 years. Mean low-density lipoprotein cholesterol (LDL-C) ... Related articles - All 33 versions
CM Mason, F CLS - Journal of the American Academy of Nurse …, 2009 - interscience.wiley.com Purposes: The purposes of this review were to highlight recent clinical trial
results on the safety and efficacy of statin therapy in adults aged 65 years and
older and to examine how nurse practitioners (NPs) and physician assistants ... Related articles - All 3 versions
